“The efficacy of intralesional metronidazole compared to intralesional glucantime in the therapeutic therapy of cutaneous leishmaniasis”, J Pak Assoc Dermatol, vol. 32, no. 2, pp. 348–352, Jun. 2022, doi: 10.66344/jpad.32.2.2022.1919.